SeqLL Inc. (SEQL)

Market Cap	465.19K
Revenue (ttm)	n/a
Net Income (ttm)	-5.28M
Shares Out	347.16K
EPS (ttm)	-16.40
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Open	n/a
Previous Close	1.340
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About SEQL

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. It focus on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provide solutions for various applications, ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Aug 27, 2021
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: SEQL

Financial Performance

In 2022, SeqLL's revenue was $78,659, a decrease of -62.54% compared to the previous year's $209,995. Losses were -$4.09 million, 10.6% more than in 2021.